Dr. Deric Wheeler's lab focuses on improving treatments for head and neck cancer (HNC) by exploring how certain proteins contribute to resistance against targeted therapies, specifically the drug cetuximab. By studying both human tumor samples and patient-derived models, the lab aims to understand the molecular mechanisms of resistance and to identify ways to overcome it using combinations of therapies. Their ultimate goal is to enhance treatment outcomes and refine existing therapeutic approaches for HNC patients.

Dr. Clifton David Fuller leads research focused on improving the care and quality of life for patients with head and neck cancers. His lab uses advanced imaging techniques and artificial intelligence to better detect and prevent lymphedema and fibrosis—complications that many survivors experience after treatment. By enhancing CT scans and treatment planning, the goal is to help patients face fewer long-term health issues after cancer treatment.

The research lab of Dr. Shuo Li focuses on improving the prediction and management of heart failure through advanced imaging techniques. By analyzing non-contrast low-dose CT scans, the lab aims to develop machine learning models that can identify individuals at high risk of heart failure. The lab's work combines innovative radiomics with clinical health assessments, seeking to enhance preventive strategies and ensure more personalized patient care.

Dr. Mohammed Elbaz's lab at Northwestern University is focused on revolutionizing the diagnosis and management of pulmonary hypertension (PH), particularly its severe form known as pulmonary arterial hypertension (PAH). By developing a groundbreaking non-invasive tool called the '4D Right-Heart Virtual Catheter', the lab aims to dramatically improve how healthcare providers can assess the hemodynamics of the right heart using advanced MRI scans. This innovative approach not only seeks to expedite the diagnostic process but also hopes to enhance treatment outcomes for patients suffering from this life-threatening condition.

Dr. Tamara G. Hershey's lab focuses on understanding how type 2 diabetes (T2D) affects the brain, especially in youth who are at risk due to obesity and metabolic problems. The research aims to identify the connections between metabolic disorders and changes in brain structure and function, helping to better understand the complications associated with T2D in younger populations. This research is crucial as T2D is increasingly diagnosed in children and adolescents, and studying these effects early can lead to better intervention strategies.

Timothy L. Hall's lab at the University of Michigan focuses on improving a cutting-edge method known as histotripsy, which uses high-intensity ultrasound to non-invasively destroy tissue, such as tumors in the liver. The lab aims to enhance this technique by developing advanced imaging and correction methods that ensure the treatment can be safely applied to a broader patient population. Their research could pave the way for more effective and precise medical treatments without the need for invasive surgery.

Dr. Chang Liu's lab at the University of Massachusetts Amherst focuses on innovative technologies for improving HIV detection and prevention. The team is developing a new self-test device that allows individuals to conduct HIV tests using just a drop of blood from their finger. This is designed to enhance early detection of infections and help monitor therapy effectiveness in a user-friendly way, potentially transforming HIV testing into an accessible, at-home process.

Dr. Linda Chang's lab at the University of Maryland Baltimore focuses on developing innovative treatment strategies for HIV, especially in patients with substance use disorders. The lab explores the use of MR-guided focused ultrasound technology to temporarily open the blood-brain barrier, allowing targeted delivery of HIV treatments like antiretroviral therapy and CRISPR gene editing. The ultimate goal is to eliminate HIV reservoirs in the brain and improve outcomes for those affected by HIV-associated cognitive disorders.

Professor Ian H. Holmes leads a research lab at UC Berkeley focusing on developing user-friendly bioinformatics tools for genomic analysis. The lab works on enhancing the GMOD suite, specifically JBrowse, to make genome annotations and analysis more accessible to biologists. Their innovative approaches include machine learning features to assist users in navigating complex genomic datasets and user-friendly design improvements.

Dr. Yi Hong's lab focuses on developing innovative solutions for heart repair after myocardial infarction, which has significant implications for public health. The lab is working on creating biodegradable and conductive cardiac patches that not only restore heart function but also enhance healing through the use of exosomes. This research aims to minimize the risks associated with conventional surgical procedures by employing minimally invasive techniques.

Jun Huang's lab at the University of Chicago focuses on developing innovative treatments for Alzheimer's Disease (AD) using advanced biotechnology. The lab is exploring how to engineer microglia, the brain's immune cells, to more effectively clear harmful amyloid-beta plaques associated with AD. Their work aims to create microglia that can recognize and degrade these plaques to help slow the disease's progression.

Dr. Huang Chiao Huang's lab focuses on developing innovative therapies for advanced ovarian cancer. They create 3D models that simulate the conditions of ovarian tumors in the abdomen to understand how fluid shear stress affects cancer cell behavior and treatment resistance. The lab's goal is to engineer nanoparticles that can improve the targeting and effectiveness of chemotherapy, especially in cases where cancer cells become resistant to traditional treatments.

Dr. Yiyun Henry Huang's lab at Yale University focuses on understanding and diagnosing Alzheimer's disease using advanced imaging techniques. The lab is particularly interested in the sigma-1 receptor, which plays a crucial role in the disease's progression. By developing new PET imaging agents, the lab aims to uncover important biomarkers that could lead to earlier diagnosis and better monitoring of disease treatments.

Dr. Gregory Hudalla's lab focuses on developing new therapies to reduce inflammation in the body. The research aims to create synthetic assemblies of proteins that can effectively target and treat chronic inflammatory conditions without the side effects associated with traditional drugs. By engineering these protein assemblies, the lab hopes to improve how the immune system regulates inflammation, potentially aiding millions of people suffering from chronic inflammatory diseases.

Hyunsuk Shim's lab at Emory University focuses on improving imaging techniques for better radiation therapy planning in brain cancer patients. By utilizing spectroscopic MRI, the lab aims to enhance tumor detection and guide more effective treatment strategies, potentially leading to longer survival rates for patients with aggressive brain tumors. The research is centered on developing advanced imaging methods and software tools to better identify infiltrative tumor margins that are often missed by conventional MRI.

Dr. Jeffrey Ketterling's research lab focuses on improving imaging techniques to study heart diseases in mice. By developing advanced ultrasound technology, the lab aims to detect early signs of heart dysfunction before visible changes occur. This work is crucial for understanding how blood flow patterns affect heart health and could lead to better treatment approaches for patients suffering from heart disease.

Dr. Summer Lynne Gibbs leads a research lab focused on developing innovative imaging tools to help surgeons better visualize cancerous tissues and critical nerves during surgery, particularly for prostate and cranial nerve procedures. Using advanced fluorescence guided surgery (FGS) techniques, the lab aims to create specially designed fluorescent probes that can distinguish between tumor and nerve tissues, improving surgical outcomes and reducing complications for patients. Their work addresses critical limitations in current surgical technologies to ensure safer and more effective surgeries.

Srinivasan Vedantham's lab at the University of Arizona focuses on developing and optimizing a specialized imaging technology called dedicated breast CT. This innovative method aims to provide high-resolution, 3D images of the breast without the need for physical compression, which has been a limitation of traditional mammography. The lab's ongoing research includes enhancing image reconstruction techniques and comparing the performance of breast CT against the standard digital breast tomosynthesis for more effective breast cancer screening.

Dr. Georges El Fakhri's lab at Yale University focuses on advancing imaging technologies in healthcare, particularly using PET (Positron Emission Tomography) for improved diagnosis and treatment of diseases like cancer and Alzheimer's. The lab’s research includes developing new PET scanner designs, enhancing methods for quantifying tau protein in the brain associated with Alzheimer's, and using deep learning to personalize treatment plans for prostate cancer patients receiving radionuclide therapy. Their work aims to improve patient outcomes through better imaging and treatment strategies.

Dr. Kyle D. Allen's lab at the University of Florida focuses on understanding and treating knee osteoarthritis (OA) and chronic joint pain, particularly in the knee and temporomandibular joint (TMJ). They are developing innovative approaches to deliver a special enzyme directly into the joints to reduce inflammation and improve joint health. The lab combines techniques from engineering and biology to study how nerves interact with joint tissues and how these interactions can affect pain and disability.